Insider Transactions in Q3 2021 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2021
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
350
+50.0%
|
-
|
|
Sep 24
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
350
-0.04%
|
-
|
|
Sep 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-19.83%
|
$564,140
$67.81 P/Share
|
|
Sep 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.68%
|
$1,795,198
$67.83 P/Share
|
|
Sep 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.05%
|
$670,000
$67.62 P/Share
|
|
Aug 19
2021
|
Epperly Melissa B, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,285
+3.01%
|
$430,820
$52.0 P/Share
|
|
Aug 18
2021
|
Epperly Melissa B, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,326
+0.51%
|
$68,952
$52.0 P/Share
|
|
Aug 03
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
7,779
-0.2%
|
$388,950
$50.69 P/Share
|
|
Aug 02
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.52%
|
$510,000
$51.84 P/Share
|
|
Aug 02
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-9.46%
|
$429,420
$51.75 P/Share
|
|
Aug 02
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
19,015
-0.35%
|
$969,765
$51.68 P/Share
|
|
Jul 07
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,514
-0.15%
|
$212,158
$47.04 P/Share
|
|
Jul 07
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
2,572
-0.17%
|
$120,884
$47.04 P/Share
|
|
Jul 07
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
17,804
-0.44%
|
$836,788
$47.04 P/Share
|
|
Jul 06
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,298
-0.33%
|
$954,006
$47.69 P/Share
|
|
Jul 06
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
15,798
-0.53%
|
$742,506
$47.64 P/Share
|
|
Jul 06
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
25,045
-0.6%
|
$1,177,115
$47.59 P/Share
|
|
Jul 02
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.65%
|
$490,000
$49.95 P/Share
|
|
Jul 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.47%
|
$1,366,494
$51.71 P/Share
|
|
Jul 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.3%
|
$157,233
$51.61 P/Share
|
|
Jul 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-6.84%
|
$429,420
$51.71 P/Share
|